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Protein arrays are ideal tools for the rapid analysis of whole proteomes as well as for the development of 
reliable and cheap biosensors. The objective of this proposal is to develop a new ligand assisted ligation 
method based in the naturally occurring protein trans-splicing process. This method has been used for the 
generation of spatially addressable arrays of multiple protein components by standard micro-lithographic 
techniques. Key to our approach is the use of the protein trans-splicing process. This naturally occurring 
process allows the development of a truly generic and highly efficient method for the covalent attachment 
of proteins through its C-terminus to any solid support. This technology has been used for the creation of 






















Many experimental techniques in biology and biophysics, and applications in diagnosis and drug 
discovery, require proteins immobilized on solid substrates.1-3 In fact, the concept of arrays of proteins 
attached to a solid support has attracted increasing attention over the last three years due to the sequencing 
of several genomes, including the human genome. When a genome has been deciphered, the daunting task 
of determining the function of each protein encoded in the genome still remains. Protein arrays can be used 
easily for such analysis in a parallel fashion.2,4 Another powerful application employs ordered nanometric 
arrays of proteins as nucleation templates for protein crystallization or for structural studies. Recent 
advances in nanoprinting techniques have allowed the creation of sub-micrometer arrays of proteins.5,6 All 
these applications demonstrate the use of protein arrays and also highlight the need for methods able to 
attach proteins in a well defined and ordered way onto a solid supports. 
Various methods are available for attaching proteins to solid surfaces. Most rely on non-specific 
adsorption,6,7 or on the reaction of chemical groups within proteins (mainly, amino and carboxylic acid 
groups) with surfaces containing complementary reactive groups.8,9 In both cases the protein is attached to 
the surface in random orientations. The use of recombinant affinity tags addresses the orientation issue. 
However, in most cases the interactions of the tags are reversible and therefore not stable over the course of 
subsequent assays or require large mediator proteins.10,11 Methods for the chemoselective attachment of 
proteins to surfaces has been also developed recently by our group.12-15 These methods rely in the 
introduction of two unique and mutually reactive groups on the protein and the support surface. The 
reaction between these two groups usually gives rise to the selective attachment of the protein to the surface 
with total control over the orientation.14,15 However, these methods, although highly selective, rely on 
uncatalyzed pseudo-bimolecular reactions with little or not activation at all. This lack of activation means 
that the efficiency of these bimolecular-like reactions depends strongly on the concentration of the reagents. 
A way to overcome this intrinsic entropic barrier and make attachment reactions even more efficient and 
selective, even under high dilution conditions, is through the use of a highly selective molecular recognition 
event to bring together the two reactive species. This event increases dramatically the local effective 
concentration of both reacting species thus accelerating the corresponding attachment reaction even under 
unfavorable conditions (i.e. low concentration and even in the presence of other proteins). 
The objective of this project has been to develop a new ligand assisted ligation method based in the 
naturally occurring protein trans-splicing process.16-19 This methodology has allowed the development of   a 
truly generic and highly efficient method for the covalent attachment of proteins through its C-terminus to 
any solid support. This new approach is totally traceless (i.e. the protein of interest will be directly attached 
to the surface without the requirement of large protein mediators/linkers) and it can be used for the 
generation of spatially addressable arrays of multiple protein components by using standard DNA-array or 
photo-lithographic techniques. Finally, this technology is also being used for the production of protein 
arrays some of the key protein components involved in the Type III Secretion System from the pathogenic 
bacterium Yersinia pestis, an enteric pathogen that is the causative agent of bubonic and pneumonic plague. 
Proteins from Y. pestis type III secretion system, include cytotoxins and effectors (Yops and Lcr-related 
proteins and usually referred as YOP proteins) that are secreted into eukaryotic cells and inhibit bacterial 
phagocytosis along with innate immunity and may be ideal targets for mitigating pathogenicity.20,21 
 
Background 
Most of the available methods for the chemoselective attachment of proteins to surfaces are based on 
uncatalyzed bimolecular-like reactions with little or not entropic activation at all. This lack of entropic 
activation means that the efficiency of these bimolecular-like reactions will depend strongly on the 
concentration of the reagents (i.e. on the concentration of the protein to be attached to the corresponding 
surface). This is basically due to the loss of entropy associated by the two reacting groups having to be 
brought together in the right orientation for the reaction to happen. A way to overcome this intrinsic 
entropic barrier and make ligation reactions more efficient even under high dilution conditions is using 
specific non-covalent interactions for bringing both reactive groups in close proximity (Scheme 1). Under 
these conditions the rate of bimolecular protein chemical ligation reactions should be very efficient even  
Figure 1. Attaching proteins to solid surfaces by using a protein 
trans-splicing technique. A. Principle of the protein trans-splicing 
approach for the immobilization of proteins. The C-intein fragment 
is attached to the surface and the N-intein fragment is fused to the 
C-terminus of the protein to be attached. When this fusion protein is 
exposed to C-intein-containing surface, the two intein fragments 
associate yielding a fully operational intein domain that then 
splices out attaching at the same time the protein to the surface. B. 
The attachment of proteins using this technique can be easily 
controlled by photo-caging the C-intein fragment. Under this 
conditions the intein complex can not be formed and consequently 
the protein is not attached. Only when the photo-labile group is 
removed by action of UV light the C-intein can yield the active 
intein domain which then attaches the protein to the surface. 
under high dilution conditions. This 
effect was first reported by Sheppard and 
co-workers,22 who noticed that pancreatic 
trypsin inhibitor fragments obtained by 
CNBr cleavage were able to 
spontaneously religate forming the 
original native peptide bond between 
them. The same effect was also observed 
for cytochrome C.23 In both cases, the 
two protein fragments produced after the 
CNBr cleavage, were able to 
cooperatively refold thus bringing the 
homoserine lactone at the C-terminus of one of the fragments in close proximity of the α-amino group of 
the other fragment. The high local concentration effect of these groups and the mild activation of the 
homoserine lactone functionality resulted in spontaneous amide bond formation. More recently, Mrksich 
and co-workers24 have used this same principle for the selective attachment of protein onto surfaces with 
total control over the orientation. In their approach, they used the protein calmodulin fused with the enzyme 
cutinase as a capture protein. Cutinase is a 22 kDa serine esterase that is able to form a site-specific 
covalent adducts with chorophosphonate ligands.25 In this case the ligand (a chlorophosphonate group) 
mimics the tetrahedral transition state of an ester hydrolysis. When it binds specifically to the active site of 
the enzyme, the hydroxyl group of the catalytic serine residue reacts covalently with the chlorophosphonate 
to yield a stable covalent adduct that is resistant to hydrolysis This results in the covalent and selective 
attachment of the protein to the surface through the capture protein that acts like a linker. The attachment is 
selective enough to allow the selective attachment of cutinase fusion protein from crude E. coli periplasmic 
lysates, thus demonstrating that the 
protein to be immobilized does not need 
to be purified before the immobilization 
step. 
Selective attachment of proteins by 
protein trans-splicing. One of the 
limitations of the previous approach, 
however, is that the linker between the 
protein of interest and the surface is 
always another protein. The presence of 
such a big linker could potentially give 
rise to some problems, specially in those 
applications where the attached protein 
will be involved in studying 
protein/protein interactions with complex 
protein mixtures,2,4 mainly due to 
potential cross-reactivity issues. 
In order to solve this problem, our 
group has developed a new method for 
the chemoenzymatic-like attachment of 
proteins to surfaces based on the protein 
trans-splicing process (Fig. 1).26 This 
process is similar to the protein splicing 
with the only difference that in this case 
the intein self-processing domain is split 
in two fragments (called N-intein and C-
intein, respectively).16,27-30 
These two intein fragments alone are 
inactive, however, when they are put together under the appropriate conditions they bind specifically each 
other yielding a totally functional splicing domain, which it splices itself at the same that ligates both extein 
sequences. In our approach, one of the fragments (C-intein) is covalently attached to the surface through a 
small peptide-linker meanwhile the other fragment (N-intein) is fused to the C-terminus of the protein to be 
Scheme 1. Principle for the attachment of a protein to a surface by 
using an entropically activated chemoselective reaction. 
Figure 2. Preparing a photocaged C-
intein polypeptide. A. Synthesis of a 
backbone photocaged Gly residue for 
the solid-phase peptide synthesis of 
the photocaged C-intein. B. 
Structural model of the split DnaE-
intein showing the Gly residues that 
will be photocaged in order to 
prevent the association of the C-intein 
and N-intein fragments. 
 
 
attached to the surface. The interaction between the two intein fragments allows the protein of interest to be 
immobilized onto the surface through protein trans-splicing (see Fig. 1). 
Technical Plan 
Selective protein attachment for high throughput protein chip production. Key to this approach is the use 
of the highly specific and effective protein trans-splicing process. This naturally occurring process is 
similar to the protein splicing with the only difference that in this case the intein self-processing domain is 
split in two fragments (called N-intein and C-intein, respectively). 
In our approach, one of the fragments (C-intein) is covalently 
immobilized onto the surface through a small peptide-linker (see 
Fig. 3) meanwhile the other fragment (N-intein) is fused to the C-
terminus of the protein to be attached to surface. The 
immobilization of the protein through protein trans-splicing is 
highly specific thus eliminating the need for the purification 
and/or reconcentration of the proteins prior to the immobilization 
step. More importantly, once the protein is immobilized to the 
surface, both intein fragments are spliced out into solution, 
providing a completely traceless method of attachment.  
Another key aspect of our approach is the potential to create 
spatial addressable protein arrays with multiple protein 
components using standard pholithographic techniques. This can 
be easily accomplished by creating a C-intein fragment where 
some of the key residues for the interaction with the N-intein are 
caged with a protecting group removable by UV-light (i.e. 
photocaged, see Fig. 2). This blocked C-intein fragment will be 
unable to assemble with the N-intein fused protein thus preventing 
protein trans-splicing to occur. The deprotection of these groups 
by the action of UV-light, however, allows the two intein 
fragments to assemble thus allowing the attachment of the 
corresponding protein to the surface through protein splicing (see 
Fig. 1B). Finally, the high efficiency and selectivity of this new 
protein immobilization approach allows to be easily interfaced 
with high throughput protein expression systems such as coupled 
in vitro transcription/translation systems. 
High throughput protein cloning, expression for proteins of 
interest. YOP and other proteins will be cloned using high-
throughput cloning techniques and expressed in E. coli.31 The use 
of coupled in vitro transcription/translation systems will also be 
used for high throughput screening and production of functional 
YOP proteins.26 
High throughput specific labeling of YOP proteins. YOP proteins 
will be specifically labeled with orthogonal Alexa or similar dyes 
(up to 4 different fluorescent dyes will be used for multiplexed studies) at their C- or N-termini. This allows 
the screening of the corresponding protein microarrays with up to 4 different proteins at the same time, thus 
allowing the study of potential multicomponent protein complexes. Selective labeling will be accomplished 
by using Expressed Protein Ligation (EPL).32,33 Briefly, this novel methodology allows the chemosective 
ligation at the C- or N-termini of the protein of interest to a small synthetic peptide that is specifically 
labeled with a particular fluorescent dye. 
Results 
Site-specific immobilization of proteins through protein trans-splicing. We have developed a new 
traceless capture ligand approach for the selective immobilization of proteins through their C-termini to a 
modified glass surface (Figure 1). Our approach is based on the use of protein trans-splicing 16,34, which is a 
naturally occurring process similar to protein splicing 17,19,35,36 with the difference that the intein self-
processing domain is split in two fragments (called N-intein and C-intein, respectively). These two intein 
fragments are inactive individually. However, they can bind each other with high specificity under 
appropriate conditions to form a functional protein splicing domain. In our approach, the C-intein fragment 
is covalently immobilized onto a glass surface through a PEGylated-peptide linker while the N-intein 
Figure 3. Structures of linkers 1 and 2 used for the 
derivatization of glass slides to be used in the immobilization 
of proteins through protein trans-splicing. 
fragment is fused to the C-terminus of the protein to be attached to surface. When both intein fragments 
interact, they form an active intein domain, which ligates the protein of interest to the surface at the same 
time the split intein is spliced out into solution (Figure 1). 
Key to our approach is the use of the naturally split DnaE intein from Synechocystis sp. PCC6803.16 The C- 
and N-intein fragments of the DnaE intein are able to self-assemble spontaneously (Kd = 0.1-0.2 µM)26 not 
requiring any refolding step. The DnaE intein-mediated trans-splicing reaction is also very efficient under 
physiological-like conditions (τ1/2 ≈ 4 h and trans-splicing yields ranging from 85% to almost 
quantitative)26. The effect of pH and temperature on trans-splicing mediated by the naturally split DnaE 
intein from Synechocystis sp. PCC6803 has been also extensively studied.18 The optimal pH for trans-
splicing is around 7.0, however, the trans-splicing reaction was also relatively efficient at pH values 
ranging from 5 to 8. To test the suitability of protein trans-splicing for selective protein immobilization 
onto solid surfaces, we used two model proteins, Maltose Binding Protein (MBP) and Enhanced Green 
Fluorescent Protein (EGFP). Both proteins were modified at the DNA level to append the DnaE N-intein 
fragment (IN, residues 1-123 of the DnaE 
intein) at their C-termini. The two fusion 
proteins (MBP-IN and EGFP-IN) were 
readily expressed in E. coli and purified by 
affinity chromatography. In order to enable 
the site-specific attachment of the IN fusion 
proteins onto a glass surface, an amine-
functionalized glass slide was first treated 
with maleimidopropionic acid N-
hydroxysuccinimide ester (MPS) and then 
reacted with a mixture of PEGylated thiol 
linkers 1 and 2, in a molar ratio of 3:97, 
respectively (Figure 3). Both linkers contain 
a PEG moiety, which prevents non-specific 
interactions and also acts as a hydrophilic 
spacer, minimizing any detrimental 
interaction between the attached protein and the glass surface.13 
Linker 1 contains the DnaE C-intein fragment (IC, residues 124-159 of the DnaE intein) followed by the 
corresponding C-extein sequence CFNK. The Cys residue in the C-extein sequence was protected with a S-
tBu protecting group. This was 
required to ensure that the IC-
containing linker was 
selectively immobilized 
through its PEGylated terminal 
thiol onto the maleimido-
coated glass surface (Figure 3). 
Linker 2 was used as diluent to 
control the density of reactive 
sites on the modified glass 
surface. When the 
derivatization was complete, 
the S-tBu protecting group on 
the Cys residue was removed 
with 50% β-mercaptoethanol in dimethylformamide (DMF) for 2 h. The surface was washed and 
immediately used for spotting. Dried IC-coated glass slides could be stored for several months at -20°C 
before being used. In order to increase the stability of the IC polypeptide, however, the dried IC-coated glass 
should be stored with the C-extein Cys residue protected. 
Figure 4. Selective attachment of EGFP-IN (green) and MBP-IN (red) onto derivatized glass slides. (a) 
Epifluorescence image of an IC-coated glass slide after the spotting of different concentrations of EGFP-IN and 
EGFP (top) and after buffer washes (bottom). (b) Different concentrations of MBP-IN were spotted onto a PEG- 
(top) and IC-coated (bottom) glass slides. After washing, the immobilized MBP was detected by 
immunofluorescence. 
 Different concentrations of pure EGFP-IN and MBP-IN fusion proteins were spotted onto IC-coated glass 
slides (Figure 4). As a control, a solution of EGFP with no IN fragment was spotted in the same slide 
(Figure 4a). Also, a solution of MBP-IN was spotted onto a glass slide derivatized with only the non-
functional linker 2 (Figure 4b). The trans-splicing reaction was incubated for 16 h in a humidified chamber 
at 37°C. As shown in Figure 4, only specific immobilization of the proteins containing the IN polypeptide to 
the IC-containing glass surfaces was observed. No fluorescent signal was detected from the control protein 
EGFP, lacking the IN polypeptide, after washing (Figure 4a). Also, the MBP binding was minimal when the 
trans-splicing active MBP-IN fusion protein was spotted onto a control glass slide coated with the non-
functional linker 2 (Figure 4b, top panel). The trans-splicing mediated attachment of EGFP and MBP in 
both cases was efficient in a range of concentrations (Figure 4). Also, it is interesting to note that the 
attached EGFP retained its characteristic green fluorescence, indicating that its tertiary structure was 
unaffected by the attachment to the PEGylated glass surface. The covalent nature of the new bond formed 
between the C-terminus of the protein and the modified surface was confirmed by washing a glass slide 
Figure 5. Selective immobilization of MBP-IN from complex mixtures. (a) Soluble cellular fraction of E. coli cells 
overexpressing MBP-IN. (b) MBP-IN expressed in vitro using a cell-free system. Protein concentrations in the cell 
lysate and IVT crude reaction were estimated by Western Blotting. In both cases, MBP was detected by 
immunofluorescence after washing. The level of non-specific background can be seen at the bottom of the slide 
when MBP with no DnaE N-intein was spotted. 
 
Figure 6. Expression and characterization of the different photocaged versions of the DnaE C-intein 
polypeptide. (a) Sequences of the different photocaged IC polypeptides synthesized in this project. Chemical 
structure of the protecting group used to photocaged the Gly residue (b) Characterization of purified products 
by analytical HPLC and ES-MS. (c) HPLC and ES-MS analysis of the photodeprotection reaction for IC 31G* 
performed with UV light at 365 nm for 30 min. 
containing immobilized MBP with a 2% SDS solution (SDS solutions above the critical micelle 
concentration have been previously used to desorb non-specifically adsorbed proteins10 as well as to disrupt 
specific protein/protein interactions37). Once the stringent wash was complete and the glass slide was re-
stained to detect the remaining attached MBP, no significant loss of fluorescence was detected. This result 
confirms that the immobilization of the proteins to the surface proceeds mostly through the formation of a 
stable covalent bond and not through a transient affinity interaction. 
The ability to selectively immobilize IN-containing fusion proteins from complex mixtures through protein 
trans-splicing has been also explored. Hence, MPB and MBP-IN fusion proteins were overexpressed in E. 
coli, and the corresponding soluble cellular fractions were spotted onto IC-coated glass slides as described 
above. As before, the immobilization of the MBP protein containing the IC polypeptide was extremely 
selective with minimal background (Figure 5a). Encouraged by these results, we investigated the possibility 
of interfacing this new immobilization technique with cell-free expression systems. Thus, the MBP-IN was 
expressed using an E. coli-based in vitro transcription/translation (IVT) system. The crude IVT reaction 
was spotted without further treatment, and it was processed as described above. As before, the MPB protein 
was selectively attached to the IC-coated glass surface (Figure 5b). In both cases, the amount of 
immobilized protein was shown to be similar. 
 
Photomodulation of protein trans-splicing. Several photocaged DnaE C-intein polypeptides were 
successfully synthesized using optimized Fmoc-based Solid-Phase Peptide Synthesis (Figure 6). After 
purification by preparative HPLC, the purified photocaged peptides were characterized by analytical HPLC 
and mass spectrometry (Figure 6b). Removal of the o-nitrobenzyl backbone protecting group was 
efficiently accomplished by irradiating for 30 min with UV light at 365 mn a solution of the corresponding 
photocaged peptide (Figure 6c). The binding affinities of the different photocaged C-intein polypeptides for 
the unmodified N-intein polypeptide were also studied by fluorescence anisotropy. As shown in Figure 7, 
the dissociation constant for the C-intein polypeptides containing only one photocaged Gly residue was 
around six times weaker than the wild type C-intein polypeptide. The polypeptide containing two 
photocaged Gly residues (IC 19G*,31G*), on the other hand, showed an affinity constant for the N-intein 
significantly much weaker, around 37 times lower than the observed for the wild-type IC. The trans-splicing 
activity of all the photocaged C-intein polypeptides was also tested using MBP-IN. All the single 
photocaged IC polypeptides showed significant decreases in their ability to promote trans-splicing as shown 
in Figure 8a. Polypeptide IC 31G* was by far the more efficient in preventing trans-splicing, showing only 
a 10% of the trans-splicing activity of the IC wt polypeptide (Figure 8a) under the same reaction conditions. 
IC 19G* and 6G* both showed ≈30% of the IC wt trans-splicing activity. IC 11G* was the less efficient of the 
group preventing trans-splicing, showing around 60% of the IC wt activity. In contrast, the polypeptide IC 
Figure 7. Isotherm binding curves for the interaction between MBP-IN and the different photocaged IC 
polypeptides. Shown is the change in fluorescence polarization of fluoresceine-labeled IC as a function of added  
MBP-IN fusion protein. 
19G*,31G*, which contains two photocaged Gly residues, was able to completely prevent trans-splicing 
activity (Figure 7b).   
High throughput protein cloning, expression for proteins of 
interest. During the duration of this project several Yop-DnaE IN 
fusion proteins have been cloned and expressed in E. coli and cell-
free systems (see Figure 9). Yop proteins from Co92 strain were 
amplified by PCR using genomic DNA (kindly provided by 
Matthew Coleman/Emilio Garcia, CMLS). The DNA fragments 
were purified and inserted between the Nde I and BamH I 
restriction sites of either a DnaE-IN-pIVEX2.3 plasmid (Roche 
Diagnostics) or DnaE-IN-pET28a plasmid. In vivo and in vitro 
expression and characterizations was carried out as previously 
described.26 
 
Significance and potential results.  
The ability of attaching proteins to a solid support in an ordered 
fashion is expected to play a critical role in several key applications 
in the field of biology and biophysics. For example, the creation of 
functional protein microarrays is critical for the progress in 
proteomics research. Like DNA chips, protein chips allow the 
analysis of thousand of proteins simultaneously for the rapid 
discovery of new drug targets.  
We have started a  collaborative effort to use this newly developed 
technology to create protein arrays capable of characterizing 
known and unknown protein interactions involved in the Type III 
Secretion System from the pathogenic bacterium Y.pestis. This 
human pathogen is the etiologic agent of bubonic and pneumonic 
plague and it has been recognized as one of the most devastating, 
epidemic-causing bacteria experienced by mankind. Although 
plague is not a public health problem in most parts of the world, its 
potential for contagion, the lack of an effective vaccine, and the 
recent emergence of multiple antibiotic-resistant strains place this 
organism squarely at the top of the United States' select agent list 
as a potential candidate for bioterrorism use. For these reasons, the 
development of highly effective anti-plague 
treatments, particularly to combat strains of Y. 
pestis resistant to traditional drugs is an 
immediate public health priority. 
The use of Yop-based protein microarrays will 
provide an invaluable tool to study and 
establish new protein-protein interactions 
under different environmental conditions as 
potential targets to mitigate pathogenicity. 
Therefore, these Yop-based protein 
microarrays could also be used for rapid 
screening of chemically synthesized libraries 
to identify potential inhibitors of key protein 
interactions for virulence in Y. pestis. 
 
Exit Plan 
This whole project aligns extremely well with 
the National Institute of Allergy and Infectious 
Diseases (NIAID) and Department of 
Homeland Security (DHS) strategic plan for 
Figure 8. Trans-splicing activity of 
single (a) and double (b) photocaged 
DnaE IC polypeptides with MBP-IN 
fusion protein. In all the cases the 
trans-splicing reactions were carried 
out under the same conditions. 
Reactions were analyzed by SDS-
PAGE. The trans-spliced product 
MBP-CFNK was isolated by 
analytical HPLC and characterized 
by mass spectrometry (data not 
shown). 
Figure 9. Expression of several Yop-IN fusion protein in E. 
coli (a) or in cell-free systems (b). The target proteins are 
indicated by an arrow. 
biodefense research and the LLNL responsibilities to homeland security. We anticipate that on the bases of 
results obtained from this proposal, we would be in a very competitive position to apply for external 
funding from NIAID and DHS. 
 
Summary 
In summary, we have demonstrated a new strategy for the site-specific immobilization of proteins onto 
solid supports by protein trans-splicing. The immobilization of the protein is highly specific and efficient 
thus eliminating the need for the purification and/or reconcentration of the proteins prior to the 
immobilization step. More importantly, once the protein is immobilized to the surface, both intein 
fragments are spliced out into solution, providing a completely traceless method of attachment. Finally, this 
methodology can be easily interfaced with cell-free protein expression systems, allowing for rapid access to 
the high-throughput production of protein chips.  
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